A team of neurologists affiliated with multiple institutions in Spain and the U.S. has found evidence that suggests up to 20% of all cases of Alzheimer’s disease (AD) may be attributable to double copies of the APOE4 gene.
A team of neurologists affiliated with multiple institutions in Spain and the U.S. has found evidence that suggests up to 20% of all cases of Alzheimer’s disease (AD) may be attributable to double copies of the APOE4 gene.